These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9770237)

  • 1. [ABC transporters in human cells].
    Bartosz G
    Postepy Biochem; 1998; 44(2):136-51. PubMed ID: 9770237
    [No Abstract]   [Full Text] [Related]  

  • 2. Regulation of ion channels by ABC transporters that secrete ATP.
    al-Awqati Q
    Science; 1995 Aug; 269(5225):805-6. PubMed ID: 7543697
    [No Abstract]   [Full Text] [Related]  

  • 3. [Sulfonylurea receptors].
    Huupponen R
    Duodecim; 1989; 105(19):1578-80. PubMed ID: 2553390
    [No Abstract]   [Full Text] [Related]  

  • 4. Properties and functions of ATP-sensitive K-channels.
    Ashcroft SJ; Ashcroft FM
    Cell Signal; 1990; 2(3):197-214. PubMed ID: 2119205
    [No Abstract]   [Full Text] [Related]  

  • 5. Intracellular localization and molecular heterogeneity of the sulphonylurea receptor in insulin-secreting cells.
    Ozanne SE; Guest PC; Hutton JC; Hales CN
    Diabetologia; 1995 Mar; 38(3):277-82. PubMed ID: 7758873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promiscuous coupling between the sulphonylurea receptor and inwardly rectifying potassium channels.
    Ammälä C; Moorhouse A; Gribble F; Ashfield R; Proks P; Smith PA; Sakura H; Coles B; Ashcroft SJ; Ashcroft FM
    Nature; 1996 Feb; 379(6565):545-8. PubMed ID: 8596634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [ATP-sensitive potassium channel--sulfonylurea receptor].
    Yamada Y; Sunaga Y
    Nihon Rinsho; 1997 Oct; 55 Suppl():458-62. PubMed ID: 9392149
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacology of glimepiride].
    Satoh Y
    Nihon Rinsho; 1997 Nov; 55 Suppl():147-51. PubMed ID: 9434459
    [No Abstract]   [Full Text] [Related]  

  • 9. ATP-sensitive K+ channels: paradigm lost, paradigm regained.
    Philipson LH
    Science; 1995 Nov; 270(5239):1159. PubMed ID: 7502039
    [No Abstract]   [Full Text] [Related]  

  • 10. P-glycoprotein inhibition by glibenclamide and related compounds.
    Golstein PE; Boom A; van Geffel J; Jacobs P; Masereel B; Beauwens R
    Pflugers Arch; 1999 Apr; 437(5):652-60. PubMed ID: 10087141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUR receptor activity vs. incidence of hypoglycaemia and cardiovascular mortality with sulphonylurea therapy for diabetics.
    Tayek J
    Diabetes Obes Metab; 2008 Nov; 10(11):1128-9; author reply 1129-30. PubMed ID: 18671799
    [No Abstract]   [Full Text] [Related]  

  • 12. [Sulfonylurea drugs for type 2 diabetes].
    Toyota T
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():339-45. PubMed ID: 12387015
    [No Abstract]   [Full Text] [Related]  

  • 13. Truncation of Kir6.2 produces ATP-sensitive K+ channels in the absence of the sulphonylurea receptor.
    Tucker SJ; Gribble FM; Zhao C; Trapp S; Ashcroft FM
    Nature; 1997 May; 387(6629):179-83. PubMed ID: 9144288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Glimepiride].
    Nakamura N
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():351-6. PubMed ID: 12387017
    [No Abstract]   [Full Text] [Related]  

  • 15. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sulfonylurea receptors and mechanism of sulfonylurea action.
    Panten U; Schwanstecher M; Schwanstecher C
    Exp Clin Endocrinol Diabetes; 1996; 104(1):1-9. PubMed ID: 8750563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial sulfonylurea receptor: identification and characterization.
    Szewczyk A; Wójcik G; Lobanov NA; Nałecz MJ
    Biochem Biophys Res Commun; 1997 Jan; 230(3):611-5. PubMed ID: 9015372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The actions of a novel potent islet beta-cell specific ATP-sensitive K+ channel opener can be modulated by syntaxin-1A acting on sulfonylurea receptor 1.
    Ng B; Kang Y; Elias CL; He Y; Xie H; Hansen JB; Wahl P; Gaisano HY
    Diabetes; 2007 Aug; 56(8):2124-34. PubMed ID: 17496234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of the glycaemic effects of sulfonylureas.
    Ashcroft FM
    Horm Metab Res; 1996 Sep; 28(9):456-63. PubMed ID: 8911983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes.
    Meyer M; Chudziak F; Schwanstecher C; Schwanstecher M; Panten U
    Br J Pharmacol; 1999 Sep; 128(1):27-34. PubMed ID: 10498831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.